Description

The ESC Textbook of Heart Failure is the latest addition to the European Society of Cardiology (ESC) publications portfolio and is fully supported by the European Heart Failure Association.

The textbook brings together internationally renowned experts in the field of heart failure to present an up-to-date understanding of all aspects of this chronic condition that worsens with time. It is estimated that the worldwide population of patients suffering from heart failure is approximately 26 million. This clinically oriented work reflects contemporary European guidelines from the ESC and the European Heart Failure Association and summarizes the latest evidence from clinical trials.

A must read for cardiovascular healthcare specialists in Europe and across the world it should also appeal to those in training, general physicians and those caring of the elderly, cardiothoracic surgeons, primary care doctors, and specialist nurses too.

Table of contents

Section 1: Universal definition of heart failure

1.1:Universal definition of heart failure, Andrew JS Coats, Biykem Bozkurt and Petar M. Seferovic

Section 2: Epidemiology of heart failure

2.1:Epidemiology of heart failure, Amy Groenewegen, Ivan Milinkovi?, Arno W Hoes, Arend Mosterd, Frans H Rutten

Section 3: Etiology of heart failure

3.1:Coronary artery disease, (Rocco Antonio Montone, Maurizio Volterrani, Jian Zhang and Filippo Crea

3.2:Hypertension, Athanasios Manolis and Yuri Lopatin3.3:Valvular heart disease, Ana Pardo Sanz, Ivan Milinkovic and Josep Zamorano

3.4.1:Genetic basis of cardiomyopathies, Thomas Thum, Stephane Heymans, and Johannes Backs3.4.2:Dilated and hypokinetic non-dilated cardiomyopathy, Petar M.Seferovic, Biykem Bozkurt, and Marija Polovina

3.4.3:Hypertrophic cardiomyopathy, Perry Elliott, Michel Noutsias and Aris Anastasakis

3.4.4:Restrictive cardiomyopathy, Claudio Rapezzi, Alberto Aimo, Ales Linhart, and Andre Keren

3.4.5:Arrhythmogenic right ventricular cardiomyopathy, Cristina Basso, Hugh Calkins and Domenico Corrado

3.4.6:Peripartum cardiomyopathy, Karen Sliwa and Johann Bauersachs

3.4.7:Takotsubo cardiomyopathy, Jelena Templin-Ghadri, Michael Würdinger, Johann Bauersachs, and Christian Templin

3.5:Myocarditis and pericarditis, Stephane Heymans, Arsen Risti?, Yehuda Adler, and Massimo Imazio

3.6:Congenital heart disease, Werner Budts and Jolien Roos-Hesselink3.7:Endocrine and metabolic disorders, Martin Huelsmann, Jelena Seferovic and Francesco Cosentino

3.8:Obesity, Lina Badimon, Stefan Anker and Stephan von Haehling

3.9:Cancer and cancer therapy, Alexander Lyon, Dimitrios Farmakis, Daniela Cardinale and Teresa Lopez Fernandez

3.10:Toxins (e.g. alcohol etc.) and infections, Antonello Gavazzi, Maria Nunes, and Fausto Pinto

Section 4: Prevention of heart failure

4.1:Prevention of heart failure, Massimo Piepoli, Maria Benedetta Matrone, Paul Dendale, and Shelley Zieroth

Section 5: Pathophysiology of heart failure

5.1:Molecular and cellular mechanisms, (Junjie Xiao, Thomas Thum, Gianluigi Condorelli and Johannes Backs

5.2:Alterations in myocardial metabolism, Edoardo Bertero and Chistoph Maack

5.3:Ventricular remodelling, Javier Diez Martinez and Hans-Peter Brunner La Rocca

5.4:Neurohormonal activation, Antoni Bayes Gennis and Faiez Zannad

5.5:Immune-mediated mechanisms, Urlich Hofmann, Stefan Frantz and Nikolaos Frangogiannis

5.6:Inflammation, oxidative stress and endothelial dysfunction, Stephane Heymans

5.7:Alterations in peripheral circulation and renal function, Alterations in peripheral circulation and renal function (

5.8:Systemic adaptations in metabolism and nutritive status, (Stephan von Haehling and Wolfram Doehner

Section 6: Clinical phenotypes of chronic heart failure

6.1:HFrEF, Thomas Luscher, Petar Seferovic, and Brian Halliday

6.2:HFmrEF, Adrian Voors, Brenda Moura, Lars Lund and Carolyn Lam

6.3:HFpEF, Rudolf De Boer, Burkert Pieske, and Barry Borlaug

6.4:Right heart failure, Thomas Luscher, Thomas M. Gorter, Susanna Price, Michael Gatzoulis and Anneline Te Riele

Section 7: Chronic heart failure: diagnostic and prognostic assessment

7.1:Clinical assessment, Michel Komajda, Piotr Ponikowski, and Evgeny Shlyakhto

7.2:Biomarkers in diagnostic and prognostic assessment, Rudolf de Boer, Antioni Bayes Genis and James Januzzi

7.3:Echocardiography, Philippe Debonnaire, Victoria Delgado, Thor Edvardsen, Bogdan Popescu, and Jeroen Bax

7.4:Nuclear medicine, Danilo Neglia and Alessia Gimelli

7.5:Cardiac computed tomography, Stephan Achenbach and Amina Rakisheva

7.6:Cardiac magnetic resonance, Anna Baritussio, Noor Sharrack, Sven Plein, and Chiara Bucciarelli-Bucci

7.7:Cardiopulmonary exercise, Luca Moderato, Davide Lazzeroni, Stamatis Adamopoulos, Alain Cohen-Solal and Massimo Piepoli

7.8:Cardiac catheterization, invasive imaging and haemodynamic assessment, Christian Hamm, Brigit Assmus and Veselin Mitrovic

Section 8: Chronic heart failure: pharmacological management

8.1:Angiotensin converting enzyme inhibitors, Roberto Ferrari, Gabriele Guardigli, and Biykem Bozkurt

8.2:Angiotensin I receptor blockers, Ileana L. Pina and Magdy Abdelhamid

8.3:ARNI, Petar M. Seferovic, Michele Senni, Marija Polovina and Andrew JS Coats

8.4:Beta-blockers, Daniela Tomasoni, Marianna Adamo, Hiroyuki Tsutsui, and Marco Metra

8.5:Mineralocorticoid receptor agonists, Bertram Pitt, João Pedro Ferreira and Faiez Zannad

8.6:Ivabradine, Michael Bohm and Michel Komajda

8.7:Vasodilators, Eftihia Polyzogopoulou, Maria Nikolaou, John Parissis and Alexandre Mebazaa

8.8:Digitalis glycosides, Udo Bavendiek and Johann Bauersachs

8.9:Diuretics, Jeroen Dauw, Stephen Gottlieb and Wifried Mullens

8.10:Inotropes and inodilators, Jan Biegus, Piotr Ponikowski, and Christoph Maack

8.11:SGLT2 inhibitors, Petar M. Seferovic, Francesco Cosentino, Giuseppe Rosano and James Januzzi

8.12:Ancillary pharmacological treatment options, Stefan Agewall, Isabelle van Gelder, and Irene Savelieva

8.13:New and emerging therapies, Giuseppe Rosano, Gerasimos Filippatos, and Randall Starling

Section 9: Chronic heart failure: non-pharmacological management

9.1:Implantable cardioverter defibrillator, Gianluigi Savarese, Cecilia Linde and Kenneth Dickstein

9.2:Cardiac resynchronization therapy, Pieter Martens, Eva Goncalvesova, and Wilfried Mullens

9.3:Cardiac surgery, Felix Schoenrat, Franz-Josef Neumann, Miguel Sousa Uva and Volkmar Falk

9.4:Valve interventions, Stefan Orwat, Stefan Anker and Helmut Baumgartner

9.5:Ancillary procedures, Andrew JS Coats, Piotr P Ponikowski, Maria-Rosa Costanzo and William T. Abraham

9.6:Cardiac rehabilitation, Maurizio Volterrani, Alain Cohen-Solal, Stamatis Adamopulos, Dimitris Miliopoulos, Ferdinando Iellamo, and Massimo Piepoli

Section 10: Acute heart failure

10.1:Acute heart failure: diagnostic and prognostic assessment, Ovidiu Chioncel, Gerasimos Filippatos, Alexandre Mebazaa, Veli-Pekka Harjola, and Josep Masip

10.2:Acute heart failure: management, Katerina Fountoulaki, John Parissis, Sean Collins, Mehmet Birhan Yilmaz, and Alexandre Mebazaa

Section 11: Advanced heart failure

11.1:Advanced heart failure: assessment, Tuvia Ben Gal, Mariell Jessup, and Maria-Rosa Costanzo

11.2:Advanced heart failure: management, Daniela Tomasoni, Marianna Adamo, and Marco Metra

11.3:Mechanical circulatory support, Mandeep Mehra and Finn Gustafsson

11.4:Heart transplantation, Davor Milicic, Mandeep Mehra, and Randall Starling

11.5:Palliative care and end-of-life management, Tiny Jaarsma, Donna Fitzsimons, Lisa Hjelmfors, Loreena Hill, Ekaterini Lambrinou, and Anna Strömberg

Section 12: Comorbidities and clinical conditions

12.1:Chronic kidney disease: Clinical Aspects of Chronic Kidney Disease in Heart Failure, Pieter Martens and Hans-Peter Brunner-La Rocca

12.2:Dyskalaemia, Javed Butler, Wilfried Mullens and Kevin Damman and João Pedro Ferreira

12.3:Chronic lung disease, Josep Masip, Karina Portillo and Mattia Arrigo

12.4:Ventilatory Abnormalities and Sleep Disordered Breathing, Piergiuseppe Agostoni, Elisabetta Salvioni, Maria Rosa Costanzo, and Andrew JS Coats

12.5:Pulmonary hypertension, Irene M. Lang and Stephan Rosenkranz

12.6:Cardiac rhythm disorders, Silvia Priori, Alessandro Trancuccio, Alessia Chiara Latini, Carlo Arnò, Deni Kukavica, and Andrea Mazzanti

12.7:Management of atrial fibrillation in heart failure, Paulus Kirchhof, Andreas Metzner, Ruben Schleberger and Douglas Packer

12.8:Diabetes, metabolic syndrome and endocrine disorders, Giuseppe Rosano, Javed Butler, Petar M. Seferovi?, Jelena Seferovic and Francesco Cosentino

12.9:Systemic immune medicated diseases, Giacomo De Luca, Luca Moroni, Alessandro Tomelleri, R Marcolongo, Lorenzo Dagna, Alida LP Caforio, and Marco Matucci-Cerinic

12.10:Liver and gut dysfunction, Yuri Lopatin and Gianluigi Savarese

12.11:Anaemia and iron deficiency, Ewa Jankowska, Piotr Ponikowski, and Stefan Anker

12.12:Depression and cognitive impairment, Wolfram Doehner, Cristiana Vitale, and Mehmet Birhan Yilmaz

12.13:Cancer, Alexander Lyon, Dimitrios Farmakis, Rudolf de Boer, and Yuri Belenkov

12.14:Pregnancy, Johann Bauersachs, Denise Hilfiker-Kleiner and Karen Sliwa

12.15:Frailty, Ewa Jankowska, Cristiana Vitale and Dong-Ju Choi

Section 13: Self-care and patient education

13.1:Self-care and patient education, Tiny Jaarsma, Loreena Hill, Ekaterini Lambrinou, Anna Stromberg, and Tina Hansen

Section 14: Multidisciplinary approach to heart failure management

14.1:Multidisciplinary approach to heart failure management, Loreena Hill, Friedrich Koehler, Tiny Jaarsma, Marija Polovina, Katherine McCreary, and Andrew JS Coats

Section 15: Clinical trial design and interpretation

15.1:Clinical trial design and interpretation, Gianluigi Savarese, Marija Polovina and Gerasimos Filippatos

Section 16: Digital health in heart failure

16.1:Digital health in heart failure, Arvind Singhal and Martin Cowie

Section 17: Big data in heart failure

17.1:Big data in heart failure, Mamas Mamas and Dipak Kotecha

Section 18: Telemedicine and remote monitoring

18.1:Telemedicine and remote monitoring, Tarek Bekfani, Friedrich Koehler and William T. Abraham